Overview: French pharmaceutical company Sanofi SA is being probed by the United States Department of Justice (DOJ) over its disclosures of the blood-thinning medication Plavix. According to the company’s annual report, the DOJ is conducting the investigation over claims made to the U.S. Food and Drug Administration (FDA). The company Is already facing a number of lawsuits over Plavix, including one filed by the West Virginia’s attorney general, alleging that it misrepresented the drug.
- Sanofi’s annual report reveals that the company is being investigated by the DOJ over disclosures made to the FDA over Plavix
- In 2010, the FDA added a blackbox warning stating that 3 percent of the population can’t properly metabolize Plavix
- Late last year, West Virginia’s attorney general filed a deceptive marketing lawsuits against the company alleging that the state had needlessly been forced to overpay for Plavix because they had falsely marketed it as superior to aspirin for certain treatments
Product: Plavix® (clopidogrel)
Manufacturer: Sanofi-Aventis, Bristol-Myers Squibb Co.
Side Effects & Complications
- Cerebral hemorrhage
- Thrombotic Thrombocytopenic Purpura (TTP)
- Gastrointestinal bleeding
- Internal bleeding
- Bone marrow damage
- Heart attack